Open AccessChronic active Epstein-Barr virus infection treated with PEG-aspargase: A case report
Author(s) -
Dongmei Song,
Jingshi Wang,
Leilei Chen,
Zhao Wang
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i26.7845
Subject(s) - medicine , virology , peg ratio , virus , epstein–barr virus infection , epstein–barr virus , finance , economics
Chronic active Epstein-Barr virus infection (EBV) is a systemic EBV-positive lymphoproliferative disease, which may lead to fatal illness. There is currently no standard treatment regimen for chronic active EBV (CAEBV), and hematopoietic stem cell transplantation is the only effective treatment. We here report a CAEBV patient treated with PEG-aspargase, who achieved negative EBV-DNA.